HUNHuntsman Corporation

$8.13-15% 1Y

Is the business good?

Watch

More warning than reassurance: 2 of 9 health tests passed and margins compressing.

2 to watch, 2 without data
Fundamental health (F-score)2 / 9SEC EDGAR · Dec 31, 2025

Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.

Margin direction, 3 years−8.8 ptsderived

Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Leverage (Debt/EBITDA)bottom 3% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is HUN?

Huntsman Corporation earns −3.4% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

−3.4%

Return on invested capital · cost of capital 9.0% · 12 points below what the capital costs: growth destroys value

Share count, year on year
+0.35%

Share count, year on year · flat: no meaningful dilution

Operating margin by fiscal year
YearOperating margin
FY20208.0%
FY20219.5%
FY20228.4%
FY20231.4%
FY2024−0.41%
FY2025−2.3%
Details›
Free cash flow, trailing twelve months
$135M
Net income, trailing twelve months
−$332M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
−3.4%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.